Crestline Management’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Crestline Management’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-49,840	Closed	-$496K	–	309
2022 Q2	$496K	Hold	49,840	–	–	0.06%	168
2022 Q1	$493K	Sell	49,840 -1,375	-3%	-$13.5K	0.06%	180
2021 Q4	$504K	Hold	51,215	–	–	0.04%	172
2021 Q3	$503K	Hold	51,215	–	–	0.05%	163
2021 Q2	$502K	Buy	+51,215	New	+$500K	0.04%	125

Crestline Management's ISLE Position: Q3 2022 in Review

Crestline Management sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 49,840 shares — an estimated $496K sold.

Crestline Management first reported a position in ISLE in Q2 2021 and held it in 5 quarters. The position peaked at $504K in Q4 2021. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

Crestline Management reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
Crestline Management sold 49,840 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $496K.
Crestline Management first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2021 and held it in 5 quarters.
Crestline Management's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $504K in Q4 2021.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Crestline Management's 13F filing for Q3 2022, filed 14 Nov 2022.